Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3
Author:
Affiliation:
1. Division of Gastroenterology; Beth Israel Deaconess Medical Center; Boston MA USA
2. Harvard Medical School; Boston MA USA
3. Liver Center; Beth Israel Deaconess Medical Center; Boston MA USA
Publisher
Wiley
Subject
Virology,Infectious Diseases,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12168/fullpdf
Reference67 articles.
1. Global burden of disease (GBD) for hepatitis C;World Health Organization;J Clin Pharmacol,2004
2. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel;Cornberg;Liver Int,2011
3. Sofosbuvir for previously untreated chronic hepatitis C infection;Lawitz;N Engl J Med,2013
4. Hepatitis C therapy in non-genotype 1 patients: the near future;Wartelle-Bladou;J Viral Hepat,2012
5. Isolation of a cDNA derived from a bloodborne non-A, non-B hepatitis genome;Choo;Science,1989
Cited by 59 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC‐MS/MS cancer cell entrapment assays;Chemical Biology & Drug Design;2024-03
2. Effectiveness and Safety of Sofosbuvir-Velpatasvir in Patients with Cirrhosis Associated with Genotype 3 Hepatitis C Infection in Xinjiang, China;Infection and Drug Resistance;2022-11
3. Emergence of resistance against direct acting antivirals in chronic HCV patients: A real-world study;Saudi Journal of Biological Sciences;2021-12
4. Direct-acting Antiviral Regimens for Patients with Chronic Infection of Hepatitis C Virus Genotype 3 in China;Journal of Clinical and Translational Hepatology;2021-05-12
5. Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia;BMC Infectious Diseases;2020-01-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3